This news is delayed by 15 minutes, sign up now to get live news & full features.
NKTR NEKTAR THERAPEUTICS
+ add to watchlist
$0.65
nektar therapeutics is a leading biopharmaceutical company developing a robust pipeline of novel therapeutics based on its advanced polymer conjugate chemistry technology platform. nektar also partners with the top biopharmaceutical companies to bring new products to market. to date, nektar's technology and drug development expertise have enabled nine approved products for partners, which include leading biopharmaceutical companies.
Mkt Cap: $121.73M
52 Week High: $1.71
P/E: -1.33
52 Week Low: $0.43
Dividend: $0.00
Shares Outstanding: 186.1M